The investment bank had hired Rothschild’s London-based head of GP Solutions late last year.
2 min read · 13 March 2026
Overbay will retain control and independence of all investment activities following the investment.
2 min read · 13 March 2026
A higher percentage of LPs choosing to roll into CVs would be a ‘healthy’ sign for the market, Lexington Partners’ Christophe Browne said at NEXUS 2026.
1 min read · 13 March 2026
PEI Group’s latest GP-led Secondaries report uncovers what comes next for this burgeoning corner of the market.
2 min read · 12 March 2026
W Capital Partners believes it’s important to compound and grow assets within original funds to mitigate what it believes will become ‘more of a K-curve market’, David Wachter said at NEXUS 2026.
2 min read · 12 March 2026
From CVs on CVs to greater specialisation, secondaries professionals who have previously featured on our rising stars list share their insights on the market’s evolution.
6 min read · 12 March 2026
The asset manager’s investment chief cites ‘weird time arbitrage’ that the practice causes for evergreen investors who buy into vehicles at similar points.
5 min read · 12 March 2026
The two managers have teamed up to target $1bn for a fund that will focus on growth equity and late-stage venture capital investments, Secondaries Investor has learned.
2 min read · 12 March 2026
The platform will focus on opportunities in the US and Europe, with future growth contingent upon its track record.
2 min read · 12 March 2026